Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications